Concomitant myeloproliferative and lymphoproliferative neoplasms, distinct progenitors: A case report and review of the literature

Marchetti M, Carobbio A, Capitoni E and Barbui T: Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review. Am J Hematol. 93:698–703. 2018. View Article : Google Scholar : PubMed/NCBI

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD and Jaffe ES: The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 127:2375–2390. 2016. View Article : Google Scholar : PubMed/NCBI

Strati P and Shanafelt TD: Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: Diagnosis, natural history and risk stratification. Blood. 126:454–462. 2015. View Article : Google Scholar : PubMed/NCBI

Duarte S, Pereira SC, Rodrigues É and Pereira A: Concomitant chronic myeloid leukemia and monoclonal B cell lymphocytosis-a very rare condition. Rev Bras Hematol Hemoter. 39:167–169. 2017. View Article : Google Scholar : PubMed/NCBI

Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, et al: The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation and tumor proliferation in chronic lymphocytic leukemia. Blood. 117:563–574. 2011. View Article : Google Scholar : PubMed/NCBI

Shanafelt TD, Byrd JC, Call TG, Zent CS and Kay NE: Narrative review: Initial management of newly diagnosed, early-stage chronic lymphocytic leukemia. Ann Intern Med. 145:435–447. 2006. View Article : Google Scholar : PubMed/NCBI

Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, et al: Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood. 106:2162–2168. 2005. View Article : Google Scholar : PubMed/NCBI

Hauck G, Jonigk D, Kreipe H and Hussein K: Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms. Acta Haematol. 129:187–196. 2013. View Article : Google Scholar : PubMed/NCBI

Trifa AP, Cucuianu A, Popp RA, Paţiu M, Selicean C, Militaru MS and Pop IV: Concomitant myeloproliferative and lymphoid neoplasms in two patients positive for JAK2 V617F mutation. Case report and literature review. Indian J Hematol Blood Transfus. 30 Suppl 1:S120–S123. 2014. View Article : Google Scholar

Kodali S, Chen C, Rathnasabapathy C and Wang JC: JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN). Leuk Res. 33:e236–e239. 2009. View Article : Google Scholar : PubMed/NCBI

Henry L, Carillo S, Jourdan E, Arnaud A, Brun S and Lavabre-Bertrand T: Association of essential thrombocythemia and chronic lymphocytic leukemia: Absence of the V617F JAK2 mutation in the lymphoid compartment. Am J Hematol. 82:500–501. 2007. View Article : Google Scholar : PubMed/NCBI

Hussein K, Brakensiek K, Ballmaier M, Göhring G, Buhr T, Bock O and Kreipe H: B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur J Haematol. 77:539–541. 2006. View Article : Google Scholar : PubMed/NCBI

Gaillard JB, Carillo S, Henry L, Jourdan E and Lavabre-Bertrand T: Association of myeloproliferative and lymphoproliferative disorders. Clin Adv Hematol Oncol. 10:756–757. 2012.PubMed/NCBI

Tabaczewski P, Nadesan S and Lim SH: Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: A common defective stem cell? Leuk Res. 33:854–855. 2009. View Article : Google Scholar : PubMed/NCBI